| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 04/24/2002 | EP0841854B1 Compositions for embolizing blood vessels |
| 04/24/2002 | EP0743860B1 Preparation of hollow microcapsules |
| 04/24/2002 | EP0714298B1 Photosensitiser containing phthalocyanine derivative for photodynamic therapy of tumours |
| 04/24/2002 | CN1083280C Novel targeted compositions for diagnostic and therapeutic use |
| 04/23/2002 | US6376654 Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof |
| 04/23/2002 | US6376508 Treatments for spinal muscular atrophy |
| 04/23/2002 | US6376467 Peptide .epsilon.v1-2 is a particularly preferred inhibitory peptide. |
| 04/23/2002 | US6376248 Peptide-enhanced transfections |
| 04/23/2002 | US6375931 Contrast agents |
| 04/23/2002 | US6375929 Gene therapy for inhibition of angiogenesis |
| 04/23/2002 | US6375927 Methods of radiotherapy using biomodulators |
| 04/23/2002 | US6375926 Human leucocyte elastase (hle) inhibitor labelled with a detectable moiety where the inhibitor is synthetic and the detectable moiety is chosen from a radioactive isotope, a paramagnetic ion, a radiopaque compound and an ultrasound |
| 04/18/2002 | WO2002031202A2 High throughput genetic screening of lipid and cholesterol processing using fluorescent compounds |
| 04/18/2002 | WO2002031161A2 Regulation of human phospholipase-like enzyme |
| 04/18/2002 | WO2002030473A1 Targeted therapeutic agents |
| 04/18/2002 | WO2002030471A2 A novel system for the evaluation of the activity and/or specificity of a viral component |
| 04/18/2002 | WO2002030439A1 A nutritional dietary system, formulation, kit and method for use in preparing an individual for a predetermined activity |
| 04/18/2002 | WO2002030429A1 Combination therapy for the treatment of estrogen-sensitive disease |
| 04/18/2002 | WO2000071170A9 Novel high viscosity embolizing compositions |
| 04/18/2002 | US20020046410 Method for generating immune-compatible cells and tissues using nuclear transfer techniques |
| 04/18/2002 | US20020045849 Polyurethane gel mass; lithotripsy and hyperthermia apparatus for therapy |
| 04/18/2002 | US20020045833 Medical optical imaging scanner using multiple wavelength simultaneous data acquisition for breast imaging |
| 04/18/2002 | US20020044909 Cyanine dye bioconjugates with bioactive molecules for diagnosis and therapy, particularly for visualization and detection of tumors |
| 04/18/2002 | CA2425508A1 Targeted therapeutic agents |
| 04/18/2002 | CA2425293A1 A novel system for the evaluation of the activity and/or specificity of a viral component |
| 04/18/2002 | CA2424587A1 A nutritional dietary system, formulation, kit and method for use in preparing an individual for a predetermined activity |
| 04/18/2002 | CA2424299A1 Combination therapy for the treatment of estrogen-sensitive disease |
| 04/17/2002 | EP1119315A4 Delivery of phosphoinositide polyphosphates into cells |
| 04/17/2002 | EP1075215A4 Hyaluronan-based imaging agents |
| 04/17/2002 | EP1007561B1 Novel conjugates of opioids and endogenous carriers |
| 04/17/2002 | EP0717658B1 Polymeric surfactant-encapsulated microbubbles and their use in ultrasound imaging |
| 04/17/2002 | CN1345331A Method and composition for angiogenesis inhibition |
| 04/17/2002 | CN1345241A In vivo stain compounds and methods of use to identify dysplastic tissue |
| 04/16/2002 | US6372449 Identification of intraocular membranes and structures within the eye, which comprises instilling into the eye a trypan blue solution which solution marks in a visually identifiable manner intraocular membranes and structures within the eye |
| 04/16/2002 | US6372195 Mixed gas microbubble compositions |
| 04/16/2002 | US6372194 MRI contrast media recognizing minor environmental changes |
| 04/16/2002 | US6371904 Subcutaneous cavity marking device and method |
| 04/16/2002 | CA2103556C Bicyclopolyazamacrocyclophosphonic acids, their complexes and conjugates, for use as contrast agents, and processes for their preparation |
| 04/11/2002 | WO2002029404A1 Methods for detecting vasculopathies and tumors |
| 04/11/2002 | WO2002028441A2 Magnetic resonance imaging agents for in vivo labeling and detection of amyloid deposits |
| 04/11/2002 | WO2001072780A3 Polynucleotides for diagnosing mammary gland cancer |
| 04/11/2002 | WO2001019405A3 Magnetic nanoparticles having biochemical activity, method for the production thereof and their use |
| 04/11/2002 | WO2000057923A9 Radioactive seed with multiple markers and method for using same |
| 04/11/2002 | WO2000012493A9 Thiazoline acid derivatives |
| 04/11/2002 | US20020042545 Asymmetric oxidation of olefins to vicinal diol using osmium catalyst |
| 04/11/2002 | US20020042407 Substituted porphyrins |
| 04/11/2002 | US20020042088 Method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancer |
| 04/11/2002 | US20020042067 Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators |
| 04/11/2002 | US20020041878 Monitoring angiogenesis factor |
| 04/11/2002 | US20020041851 Method for monitoring local reaction associated with injections |
| 04/11/2002 | US20020041849 Qualitative analysis |
| 04/11/2002 | US20020041848 Chemically Specific Imaging Of Tissue |
| 04/11/2002 | CA2423675A1 Methods for detecting vasculopathies and tumors |
| 04/10/2002 | EP1195167A2 Use of a gel |
| 04/10/2002 | EP1194557A2 An interleukin-1 receptor antagonist and uses thereof |
| 04/10/2002 | EP1194441A2 Thiophene a2a receptor agonists |
| 04/10/2002 | EP1194440A2 Induction of pharmacological stress with adenosine receptor agonists |
| 04/10/2002 | EP1194173A1 X-ray guided drug delivery |
| 04/10/2002 | EP0805815B1 Use of bismuth compounds for the manufacture of medicaments for the treatment of gastric disorders caused by Helicobacter pylori |
| 04/10/2002 | EP0675727B1 Glycolipid enzyme-polymer conjugates |
| 04/10/2002 | CN1344262A Perfuoroalkylamide, prodn. thereof and use thereof in diagnostics |
| 04/10/2002 | CN1082380C Improved contrast agents |
| 04/09/2002 | US6369038 Closed antisense and sense oligonucleotides and their applications |
| 04/09/2002 | US6368853 A nucleic acid encoding a polypeptide ligand; tyrosine kinase containing immunoglobulin and epidermal growth factor homolog domains; therapy and diagnosis for angiogenesis in wound healing, inflammation or tumors |
| 04/09/2002 | US6368846 Ectoparasite saliva proteins and apparatus to collect such proteins |
| 04/09/2002 | US6368789 Screening methods to identify inhibitors of telomerase activity |
| 04/09/2002 | US6368573 Measuring myocardial function in mammal |
| 04/09/2002 | CA2083271C Fibrin binding domain polypeptides and uses and methods of producing same |
| 04/09/2002 | CA1341356C Transkaryotic implantation |
| 04/04/2002 | WO2002026998A2 Hydrolases |
| 04/04/2002 | WO2002026982A2 Secreted human proteins |
| 04/04/2002 | WO2002026776A2 Peptide-based compounds |
| 04/04/2002 | WO2002026267A2 Manganes complexes for magnetic resonance imaging |
| 04/04/2002 | WO2002026266A1 Method for early prediction of the onset of invasive cancer |
| 04/04/2002 | WO2002026193A2 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas |
| 04/04/2002 | WO2002026031A1 Method of constructing heart failure model animal |
| 04/04/2002 | WO2002000662B1 Improvements in and relating to chromophores |
| 04/04/2002 | WO2001097678A3 Imaging and targeting tumors using sickle cells |
| 04/04/2002 | WO2001056612A3 Animal model for testing of immunotherapies |
| 04/04/2002 | US20020040189 Ultrasonic perfusion measurement using contrast agents |
| 04/04/2002 | US20020040162 Contrast media for angiography |
| 04/04/2002 | US20020039999 Antinociceptive agent derivative |
| 04/04/2002 | US20020039599 Calibration; administering antiseptic compound |
| 04/04/2002 | US20020039556 Stabilised phospholipid compositions |
| 04/04/2002 | DE10046465A1 Method of determining functional residual capacity of lungs during breathing, useful in newly-born or premature babies and for determining intra-pulmonal gas distribution disorders, employs fluoro-propane |
| 04/04/2002 | CA2423953A1 Hydrolases |
| 04/04/2002 | CA2423424A1 Secreted proteins |
| 04/04/2002 | CA2423413A1 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas |
| 04/04/2002 | CA2419629A1 Mri image enhancement compositions |
| 04/04/2002 | CA2392213A1 Method for early prediction of the onset of invasive cancer |
| 04/03/2002 | EP1193260A1 Phenoxazine analogs for the treatment of amyloidosis |
| 04/03/2002 | EP1192450A1 High energy phototherapeutic agents |
| 04/03/2002 | EP1192144A1 Rhodanine derivatives and their use in inhibiting and imaging amyloids |
| 04/03/2002 | EP1192143A1 Rhodanine derivatives for use in a method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
| 04/03/2002 | EP1192131A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives |
| 04/03/2002 | EP1191947A1 Methods for treating avm' using radioactive compositions |
| 04/03/2002 | EP1191946A1 Support materials and imaging method for intraoral diagnostic purposes |
| 04/03/2002 | EP1191894A2 Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug response |
| 04/03/2002 | EP1191884A1 Absorbable sponge with contrasting agent |
| 04/03/2002 | EP0883627B1 Radionuclide labeling of vitamin b12 and coenzymes thereof |